Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction
Brought to you by

Concordia acquires several pediatric products from Shionogi

Executive Summary

Concordia Pharmaceuticals Inc. (a division of Concordia Healthcare Inc.) has acquired Kapvay (clonidine), Orapred ODT (prednisolone), and Orapred OS (prednisolone) from fellow specialty pharmaco Shionogi Inc. It has also licensed exclusive rights to Shionogi’s Ulesfia (benzyl alcohol) for head lice.
Deal Industry
  • Pharmaceuticals
    • Specialty Pharmaceuticals
Deal Status
  • Final
Deal Type
  • Alliance
    • Product Purchase
    • Marketing-Licensing

Related Companies

Advertisement
UsernamePublicRestriction

Register